SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹213 Cr | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
What is the latest Total Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹213 Cr |
| Mar2025 | ₹200 Cr |
| Mar2024 | ₹178 Cr |
| Mar2020 | ₹55 Cr |
| Mar2019 | ₹41 Cr |
How is Total Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹213 Cr | 6.40 | |
| Mar2025 | ₹200 Cr | 12.22 | |
| Mar2024 | ₹178 Cr | 222.38 | |
| Mar2020 | ₹55 Cr | 33.71 | |
| Mar2019 | ₹41 Cr | - | |
Compare Total Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹844.8 Cr | -7.4% | 23.8% | 7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -7.4% |
23.8% |
7.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses